Advarra
Advarra provides regulatory, ethics review, and clinical research technology solutions that support pharmaceutical companies, biotech firms, contract research organizations, and research sites in designing, approving, and managing clinical trials while maintaining compliance with global regulations. The company operates institutional review boards (IRBs) and offers software and services for study startup, site management, and research oversight. Advarra generates revenue through subscription software, technology-enabled services, and professional consulting to sponsors and research institutions.
- Revenue
- $350.0M
- Employees
- 1,500
- Founded
- 2017
- Headquarters
- Columbia, United States of America
What 30 Arbolus experts think of Advarra
NPS scores are strongly positive, with most respondents rating 8–10 and only one rating below 7. Renewal intent is high among larger, more established customers and moderate in pilot or lower spend scenarios. Most respondents are in the MoreThan1Year implementation stage, indicating mature adoption and stickiness, with a small fraction still piloting. Key expert themes are strong regulatory reliability, efficient review processes, and platform flexibility. Challenges revolve around cost and occasional delays. Overall Customer Sentiment: Positive
Who reviewed Advarra
- C-Suite 53% (16)
- Director 30% (9)
- Manager 17% (5)
Employer names and spend open in the full report, along with the other 27 customers.
Everything 30 customers told us about Advarra.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
33 Net Promoter Score, from 30 scored reviews- Promoters 13
- Passives 14
- Detractors 3
Cumulative NPS by month
+0 over 6 months- Apr 8
- May 8
- Jun 8
- Jul 8
- Aug 8
- Sep 8
Net Promoter Score across 4 reviews, accumulated up to each month. Category median 30 across 4 companies.
Praised
- Integrated Platform for Diverse Needs
- Structured and Centralized Review
- Efficiency and Consistency
- Enterprise Negotiation and Pricing Flexibility
Criticised
- Increasing Price with Platform Expansion
- Review Turnaround Challenges
- Accumulating Costs
- Technology Adoption Outpacing Human Oversight
What customers say
Renewal intent
Plan to renew 79%Plan to renew, by seniority
- 88% 8 answers
- 67% 3 answers
- 67% 3 answers
- 7.9/10 Average score from customers who will renew
- 7.7/10 Average score from undecided customers
Top alternatives
Most weighed by Advarra customersReport
For people who use Advarra
Do you use Advarra at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 30 customers of Advarra have already contributed
Takes a few minutes. Your identity stays anonymous.